Clinical trials

  • ZAGOCIGUAT for MELAS syndrome | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)
  • Autologous EBV-specific cytotoxic T lymphocytes for Multiple sclerosis
  • Pembrolizumab for Anal cancer | Squamous cell carcinoma of anus
  • ICT01 for Advanced-stage relapsed/refractory cancer|Malignant solid tumor|Hematological malignancy
  • Pneumococcal polysaccharide conjugate antigens (multiple serotypes) conjugated to CRM197 for Asplenia
  • Clinical trial in Focal epilepsy
  • TRASTUZUMAB DERUXTECAN for Metastatic breast cancer | Hormone receptor-positive (HR+) breast cancer | HER2-low breast cancer
  • Oxycodone hydrochloride for Coronary artery disease | Aortic valve disease | Mitral valve disease | Tricuspid valve disease
  • Ceralasertib for Advanced solid tumor
  • ORIC-944 for Prostate cancer | Metastatic prostate cancer
  • BALSTILIMAB for Metastatic colorectal cancer (pMMR/MSS) | Metastatic gastrointestinal cancers
  • ZILOVERTAMAB VEDOTIN for Diffuse large B-cell lymphoma